Benucci, M.; Bardelli, M.; Cazzato, M.; Bartoli, F.; Damiani, A.; Li Gobbi, F.; Bandinelli, F.; Panaccione, A.; Di Cato, L.; Niccoli, L.;
et al. Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65). J. Pers. Med. 2024, 14, 712.
https://doi.org/10.3390/jpm14070712
AMA Style
Benucci M, Bardelli M, Cazzato M, Bartoli F, Damiani A, Li Gobbi F, Bandinelli F, Panaccione A, Di Cato L, Niccoli L,
et al. Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65). Journal of Personalized Medicine. 2024; 14(7):712.
https://doi.org/10.3390/jpm14070712
Chicago/Turabian Style
Benucci, Maurizio, Marco Bardelli, Massimiliano Cazzato, Francesca Bartoli, Arianna Damiani, Francesca Li Gobbi, Francesca Bandinelli, Anna Panaccione, Luca Di Cato, Laura Niccoli,
and et al. 2024. "Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)" Journal of Personalized Medicine 14, no. 7: 712.
https://doi.org/10.3390/jpm14070712
APA Style
Benucci, M., Bardelli, M., Cazzato, M., Bartoli, F., Damiani, A., Li Gobbi, F., Bandinelli, F., Panaccione, A., Di Cato, L., Niccoli, L., Frediani, B., Mosca, M., Guiducci, S., & Cantini, F.
(2024). Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65). Journal of Personalized Medicine, 14(7), 712.
https://doi.org/10.3390/jpm14070712
